Jul 12 2012 2:30 PM
Russell Senate Office Building - 253
Feature Image: Capitol 1WASHINGTON, D.C.— The U.S. Senate Committee on Commerce, Science, and Transportation will hold a hearing next week on “Medication and Performance Enhancing Drugs in Horse Racing.” This hearing will examine the prevalence and use of medications and performance enhancing drugs in horse racing.
Please note the hearing will be webcast live via the Senate Commerce Committee website. Refresh the Commerce Committee homepage 10 minutes prior to the scheduled start time to automatically begin streaming the webcast.
Witness Panel 1
Mr. Barry Irwin
Chief Executive Officer
Team Valor International
Mr. Kent Stirling
Executive Director, Florida Horsemen’s Benevolent & Protective Association
Chairman, Medication Committee, National Horsemen’s Benevolent & Protective Association
Mr. Jeffrey Gural
Chairman, Newmark Grubb Knight Frank
Chairman and Managing Partner, American Racing and Entertainment, LLC
Mr. Jim Gagliano
President
The Jockey Club
Witness Panel 2
Mr. Matthew Witman
National Director
American Quarter Horse Association
Mr. Marc Paulhus
Former Director of Equine Protection and Vice President
Humane Society
Mr. Ed Martin
President and CEO
Association of Racing Commissioners International
Dr. Sheila Lyons DMV
Founder and Director, The American College of Veterinary Sports Medicine and Rehabilitation
Founder and Director, Homecoming Farm, Inc.